Samtidig indgift af ketoconazol eller erythromycin og sibutramin forhøjede plasmakoncentrationerne for sibutramins aktive metabolitter (med hhv.
As answer to the CPMP question on efficacy the MAH presented the results of four new company- sponsored clinical trials as well as a review of the published literature.